SCHEMBL3485597

SCHEMBL3485597

CC1(C)SC(CO)NC1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10662033 1.00
SCHEMBL11391091 0.85 USP2 (0.31)
SCHEMBL24446257 0.84
SCHEMBL9728211 0.75 ALDH1A1 (0.39)
SCHEMBL5870085 0.74 ARG1 (0.31)
SCHEMBL23115271 0.74 POLB (0.30)
SCHEMBL28875199 0.74
SCHEMBL10876264 0.73
SCHEMBL8701041 0.72
SCHEMBL5498766 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016550-A1 Methods for Site-Specific Pegylation IPSEN PHARMA S.A.S. (FR) 2010-01-21 US disclosed
EP-2021397-A2 METHODS FOR SITE-SPECIFIC PEGYLATION Société de Conseils de Recherches et d'Applications Scientifiques, S.A.S. (FR) 2009-02-11 EP disclosed
WO-2007139997-A2 METHODS FOR SITE-SPECIFIC PEGYLATION SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) 2007-12-06 WO disclosed
US-4775675-A Thiazolidinecarboxylic acid derivatives and treatment of liver diseases therewith BIOGAL GYOGYSZERGYAR (HU) 1988-10-04 US disclosed